About Gurunath Pharma Private Limited
Data last updated:
Gurunath Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 October 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24297DL2012PTC243065. Its GSTIN is 07AAECG9190L1Z2 (Delhi).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹13 Lakh. It is led by directors Reetu Sharma and Yavneet Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 674 Pocket – C, Ifc Gazipur, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.75 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹4.46 Lakh (net margin 0.4%) and EBITDA of ₹23.36 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.
As per MCA filings, the company has open charges of ₹2.18 Cr and satisfied charges of ₹1.95 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gurunathpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address674 Pocket – C, Ifc Gazipur, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gurunath Pharma Private Limited
The main business activity of Gurunath Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gurunath Pharma Private Limited FY 2025 filings available
Gurunath Pharma Private Limited reported revenue of ₹10.75 Cr (down 20% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Gurunath Pharma Private Limited
Revenue fell 20% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gurunath Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23.36 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.46 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gurunath Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gurunath Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gurunath Pharma Private Limited
Gurunath Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Exigo International Private Limited | ₹10.84 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Bangalore, Karnataka, India |
| Ramdas Pharma Distributors Private Limited | ₹10.82 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Thane, Maharashtra, India |
| Fairdeal Health Care Private Limited | ₹10.79 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Jalandhar, Punjab, India |
| Shreyaa Tradelinks Private Limited | ₹10.77 Cr (FY 2016) | •••• | •••• | 36.0% | •••• | Chennai, Tamil Nadu, India |
| Exa Specialities and Lifecare Private Limited | ₹10.75 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Gurunath Pharma Private Limited this company | ₹10.75 Cr (FY 2024) | •••• | •••• | -20.0% | •••• | Delhi, India |
| Abrn Pharma Private Limited | ₹10.75 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Navi Mumbai, Maharashtra, India |
| Amro Pharma Private Limited | ₹10.72 Cr (FY 2025) | •••• | •••• | -42.0% | •••• | Delhi, India |
| Genext Pharma Private Limited | ₹10.68 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Paras Medicines Private Limited | ₹10.68 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Ahmedabad, Gujarat, India |
| Kalpa Aushadhalaya Private Limited | ₹10.65 Cr (FY 2022) | •••• | •••• | -18.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Gurunath Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Gurunath Pharma Private Limited
Gurunath Pharma Private Limited is audited by KUMAR AASHISH & COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KUMAR AASHISH & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Gurunath Pharma Private Limited
Gurunath Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Reetu Sharma | Director | 26 Oct 2021 | 4 Years 11 Months | Current |
| Yavneet Kumar Sharma | Director | 01 Oct 2012 | 14 Years 0 Months | Current |
Ownership and Shareholding of Gurunath Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gurunath Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2025 | Others | ₹2.1 Cr | Open |
| 27 Sep 2024 | Others | ₹8 Lakh | Open |
| 07 Aug 2024 | Others | ₹20 Lakh | Satisfied |
| 02 Jun 2018 | Others | ₹1.75 Cr | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Gurunath Pharma Private Limited
Gurunath Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending. Status as checked on 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, East, Delhi | Court case (Civ Suit) | Filed against the company by Dr. Morepen Limited | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Gurunath Pharma Private Limited
Employment history and EPFO contributions of people linked to Gurunath Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gurunath Pharma Private Limited
Gurunath Pharma Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Reetu Sharma ceased to be Additional Director on 29 Nov 2021.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Gurunath Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gurunath Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gurunath Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gurunath Pharma Private Limited
Gurunath Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECG9190L1Z2 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gurunath Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gurunath Pharma Private Limited
Gurunath Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 October 2012 (14+ years old) and is registered under CIN U24297DL2012PTC243065.
Gurunath Pharma reported revenue of ₹10.75 Cr for FY 2024 (down 20% YoY).
Gurunath Pharma has 2 current directors:
- Reetu Sharma - Director
- Yavneet Kumar Sharma - Director
Gurunath Pharma reported a net profit of ₹4.46 Lakh (net margin 0.4%) and EBITDA of ₹23.36 Lakh (EBITDA margin 2.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gurunath Pharma is 1% over three years. In the latest year (FY 2024) revenue fell 20%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gurunath Pharma is 07AAECG9190L1Z2, registered in Delhi.
The CIN (Corporate Identification Number) of Gurunath Pharma is U24297DL2012PTC243065. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gurunath Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Gurunath Pharma was incorporated on 01 October 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Gurunath Pharma by revenue are Exigo International Private Limited, Ramdas Pharma Distributors Private Limited, Fairdeal Health Care Private Limited, Shreyaa Tradelinks Private Limited, Exa Specialities and Lifecare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Reetu Sharma ceased to be Additional Director on 29 Nov 2021. Ramesh Kumar ceased to be Director on 28 Oct 2021. Reetu Sharma was appointed as Director on 26 Oct 2021. Gurunath Pharma has 4 board changes on record in total.